Selegiline in the treatment of hypersomnolence in myotonic dystrophy: a pilot study
Authors:
- Stefania MorinoSMStefania Morino
- Marco FiorelliMFMarco Fiorelli
- Marina FioriniMFMarina Fiorini
- Franco GiubileiFGFranco Giubilei
- 1 April 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 147 (2) , 167-169
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Myotonic dystrophy with alveolar hypoventilation and hypersomnia: a clinicopathological studyJournal of the Neurological Sciences, 1995
- Selegiline in the treatment of narcolepsyNeurology, 1994
- Hypersomnia in dystrophia myotonica: a neurophysiological and immunogenetic studyActa Neurologica Scandinavica, 1991
- The pharmacology of selegiline ((−)deprenyl). New aspectsActa Neurologica Scandinavica, 1989
- Sleep-related breathing impairment in myotonic dystrophyJournal of Neurology, 1987
- Guidelines for the Multiple Sleep Latency Test (MSLT): A Standard Measure of SleepinessSLEEP, 1986
- Selegiline in NarcolepsySLEEP, 1986
- Deprenyl (selegiline): the history of its development and pharmacological actionActa Neurologica Scandinavica, 1983
- Narcolepsy and idiopathic hypersomniaNeurology, 1982
- Respiratory and Hemodynamic Study During Wakefulness and Sleep in Myotonic DystrophySLEEP, 1978